Houston Methodist Hospital, an affiliate of Weill Cornell Medical College and Texas A&M Medical College, offers an ACGME-accredited Hematology Pathology Fellowship training program, and an ACGME-accredited Selective Hematologic Pathology Fellowship training program, to physicians who have completed pathology specialty training and are interested in pursuing a career in the subspecialty of hematopathology and related research. Both programs are offered consecutively as a two-year training experience to provide broad exposure to the evaluation of hematopathological diseases, with advanced technology used to ensure accurate diagnoses. 

Two one-year hematology pathology fellowship positions are available each academic year for physicians interested in board certification in hematopathology. Training will include experience in bone marrow and lymph node pathology, immunophenotyping by flow cytometry and immunohistochemistry, molecular diagnostics, coagulation, and other areas of laboratory hematology. The program includes an in-depth hematology sign-out rotation and a cytogenetics rotation at the University of Texas MD Anderson Cancer Center, and a pediatric hematology rotation at UT Memorial Hermann Hospital and Texas Children's Hospital.  Fellows present case conferences and teach pathology residents, medical students, and clinical fellows. Laboratory management and administrative experience during the program also provide the fellows with an adequate background to understand the organization and operation of a hematopathology laboratory.

Two one-year selective hematologic pathology fellowship positions in are also available each academic year for physicians interested in academic hematopathology. Training will focus on technical and research applications in the areas of immunophenotyping by flow cytometry, immunohistochemistry, molecular diagnostics, and cytogenetics. There are specific rotations in cytogenetics, molecular genetics, and clinical service rotations for review of bone marrow and lymph node histopathology. Note: This selective hematopathology fellowship does not confer board eligibility in hematopathology.

For both fellowships it is anticipated that one or more clinical research projects will be completed during the training. State-of-the-art technologies including next generation sequencing, 8-color flow cytometry, and fluorescence-activated cell sorting are available for fellows interested in pursuing an academic career. The teaching faculty in the Department of Pathology and Genomic Medicine at Houston Methodist are internationally renowned with expertise in major subspecialty areas of both anatomic and clinical pathology. Both hematopathology fellowships are staffed by eight board-certified hematopathologists at Houston Methodist and multiple board-certified hematopathologists at the other rotating institutions

Candidates must be board certified or board eligible in Anatomic and/or Clinical Pathology. Candidates must be eligible for a Texas Physician-In-Training Permit or hold a full physician Texas licensure.

Commensurate with level of postgraduate training.

Application deadline is December 31 of the year prior to the intended fellowship year, which begins July 1.

Direct application inquiries to:
April Ewton, MD
Director, Hematopathology Fellowship Programs
   c/o Leah (Ginger) Jozwiak, Fellowship Coordinator
Department of Pathology and Genomic Medicine
Houston Methodist Hospital
6550 Fannin Street, Suite 383
Houston, TX 77030
Phone: 713-441-3496
Fax: 713-793-1178
Email: ljozwiak@houstonmethodist.org